Detection of heterogeneous vancomycin intermediate resistance in MRSA isolates from Latin America

BACKGROUND: Vancomycin is a common first-line option for MRSA infections. The heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) phenotype is associated with therapeutic failure. However, hVISA isolates are usually reported as vancomycin susceptible by routine susceptibility testing...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Antimicrob Chemother
Glavni autori: Castro, Betsy E, Berrio, Maritza, Vargas, Monica L, Carvajal, Lina P, Millan, Lina V, Rios, Rafael, Hernandez, Angie K, Rincon, Sandra, Cubides, Paola, Forero, Erika, Dinh, An, Seas, Carlos, Munita, Jose M, Arias, Cesar A, Reyes, Jinnethe, Diaz, Lorena
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2020
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7443737/
https://ncbi.nlm.nih.gov/pubmed/32562543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkaa221
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items